Medicare
Commentary
Obamacare’s 11th Anniversary Is Nothing to Celebrate
Yesterday, President Biden commemorated the 11th anniversary of the Affordable Care Act. But Americans who want affordable health insurance have little to celebrate. In Obamacare’s first decade, premiums and deductibles have skyrocketed while provider networks have shrunk. Exchange policies routinely do not cover best-in-class doctors or hospitals. And the law’s costs have ...
Health Care
Sally Pipes Talks Medicare for All on “Just the News”
Sally C. Pipes joins Just the News with Sophie Mann to discuss the changes in healthcare policy being pursued by the Biden administration. Pipes argues that the goal of these proposals is to implement a public option and bring the U.S. one step closer to a Medicare for all or single-payer ...
Commentary
No time for Medicare for All
Earlier this week, Democratic Rep. Pramila Jayapal introduced the Medicare for All Act of 2021. The bill already has 112 co-sponsors in the House of Representatives. This isn’t Jayapal’s first bid for Medicare for All. She introduced a similar bill in 2019. This time around, her argument is that the ...
Commentary
California should wake up from its single-payer dreams
Single-payer health care has new life in California. State lawmakers just introduced AB1400, legislation that would launch a government takeover of the state’s health insurance system, effectively banning private coverage and enrolling every Californian in the same plan. One of the bill’s co-authors, Assemblymember Miguel Santiago, says that putting the ...
Commentary
Healthcare Price Controls Don’t Come For Free
America’s healthcare bill continues to rise. Our tab reached $3.8 trillion in 2019, nearly $11,600 per person, according to the Centers for Medicare and Medicaid Services. Health care consumes some 17.7% of our nation’s gross domestic product. In recent months, two leading research organizations, the Rand Corporation and the Kaiser ...
Commentary
President Biden’s Bipartisan Opportunity to Reduce Patients’ Drug Costs
BY ROBERT POPOVIAN & WAYNE WINEGARDEN President Joe Biden should take advantage of a bipartisan opportunity to meaningfully reduce patients’ out-of-pocket spending on biopharmaceuticals. Seizing this opportunity requires the president to recognize that the drug cost problem exists because the current system inappropriately shifts too much of its expenditures to patients. Consider that ...
Commentary
Don’t Overreact to Rising Health Spending
U.S. healthcare spending has reached a new high, according to the latest federal data. The Centers for Medicare and Medicaid Services estimate national health expenditures reached $3.8 trillion in 2019, an increase of 4.6 percent over the previous year. That’s just under 18 percent of the national economy. It’s more ...
Commentary
The FDA’s foot-dragging on the AstraZeneca vaccine is indefensible
There’s a COVID-19 vaccine currently saving lives all over the world—but not in the U.S. That vaccine, made by British drug company AstraZeneca, proved 100% effective at preventing hospitalizations and deaths in Phase III clinical trials. British regulators authorized it for use nearly two months ago. Since then, millions of people in the U.K. have been ...
Commentary
The 340B Prescription-Drug Swindle Has Gone on Long Enough
In a hearing on Tuesday, California Attorney General Xavier Becerra revealed just how unfit he is to lead the Department of Health and Human Services. Becerra dismissed the need to reform the federal “340B” program, even though it has morphed from a good-faith effort to help low-income Americans access medicines ...
Commentary
Biden’s plan to subsidize COBRA is a waste of money
President Biden has repeatedly promised to build a fairer economy, one that “works for everyone.” But if his stimulus plan is any indication, the president has a funny definition of fairness. His $1.9 trillion proposal would force working-class Americans to cover health insurance premiums for people who have lost their ...
Obamacare’s 11th Anniversary Is Nothing to Celebrate
Yesterday, President Biden commemorated the 11th anniversary of the Affordable Care Act. But Americans who want affordable health insurance have little to celebrate. In Obamacare’s first decade, premiums and deductibles have skyrocketed while provider networks have shrunk. Exchange policies routinely do not cover best-in-class doctors or hospitals. And the law’s costs have ...
Sally Pipes Talks Medicare for All on “Just the News”
Sally C. Pipes joins Just the News with Sophie Mann to discuss the changes in healthcare policy being pursued by the Biden administration. Pipes argues that the goal of these proposals is to implement a public option and bring the U.S. one step closer to a Medicare for all or single-payer ...
No time for Medicare for All
Earlier this week, Democratic Rep. Pramila Jayapal introduced the Medicare for All Act of 2021. The bill already has 112 co-sponsors in the House of Representatives. This isn’t Jayapal’s first bid for Medicare for All. She introduced a similar bill in 2019. This time around, her argument is that the ...
California should wake up from its single-payer dreams
Single-payer health care has new life in California. State lawmakers just introduced AB1400, legislation that would launch a government takeover of the state’s health insurance system, effectively banning private coverage and enrolling every Californian in the same plan. One of the bill’s co-authors, Assemblymember Miguel Santiago, says that putting the ...
Healthcare Price Controls Don’t Come For Free
America’s healthcare bill continues to rise. Our tab reached $3.8 trillion in 2019, nearly $11,600 per person, according to the Centers for Medicare and Medicaid Services. Health care consumes some 17.7% of our nation’s gross domestic product. In recent months, two leading research organizations, the Rand Corporation and the Kaiser ...
President Biden’s Bipartisan Opportunity to Reduce Patients’ Drug Costs
BY ROBERT POPOVIAN & WAYNE WINEGARDEN President Joe Biden should take advantage of a bipartisan opportunity to meaningfully reduce patients’ out-of-pocket spending on biopharmaceuticals. Seizing this opportunity requires the president to recognize that the drug cost problem exists because the current system inappropriately shifts too much of its expenditures to patients. Consider that ...
Don’t Overreact to Rising Health Spending
U.S. healthcare spending has reached a new high, according to the latest federal data. The Centers for Medicare and Medicaid Services estimate national health expenditures reached $3.8 trillion in 2019, an increase of 4.6 percent over the previous year. That’s just under 18 percent of the national economy. It’s more ...
The FDA’s foot-dragging on the AstraZeneca vaccine is indefensible
There’s a COVID-19 vaccine currently saving lives all over the world—but not in the U.S. That vaccine, made by British drug company AstraZeneca, proved 100% effective at preventing hospitalizations and deaths in Phase III clinical trials. British regulators authorized it for use nearly two months ago. Since then, millions of people in the U.K. have been ...
The 340B Prescription-Drug Swindle Has Gone on Long Enough
In a hearing on Tuesday, California Attorney General Xavier Becerra revealed just how unfit he is to lead the Department of Health and Human Services. Becerra dismissed the need to reform the federal “340B” program, even though it has morphed from a good-faith effort to help low-income Americans access medicines ...
Biden’s plan to subsidize COBRA is a waste of money
President Biden has repeatedly promised to build a fairer economy, one that “works for everyone.” But if his stimulus plan is any indication, the president has a funny definition of fairness. His $1.9 trillion proposal would force working-class Americans to cover health insurance premiums for people who have lost their ...
